论文部分内容阅读
[目的]观察远道刺结合穴位贴敷联合西药治疗贝尔面瘫疗效。[方法]使用随机平行对照方法,将100例门诊患者按随机数字表法随机分为两组。对照组50例地巴唑10mg,口服,3次/d;维生素B1 2500μg、维生素B1 100mg,肌肉注射,1次/d。观察组50例①远道刺外关、合谷、足三里、足临泣等手足穴位,1次/d,每周6次。②穴位贴敷,每穴1贴,1次/d,贴敷时间8h。西药治疗同对照组。连续治疗2周为1疗程。观测临床症状、不同疗程痊愈例数、不良反应。连续治疗3疗程,判定疗效。[结果]治疗组痊愈45例,显效1例,有效3例,无效1例,总有效率90.00%;对照组痊愈27例,显效10例,有效11例,无效2例,总有效率54.00%。治疗组疗效优于对照组(P<0.05)。两组患者不同疗程痊愈例数比较治疗组优于对照组(P<0.05)。[结论]远道刺结合穴位贴敷联合西药治疗贝尔面瘫疗效显著,缩短疗程,值得推广应用。
[Objective] To observe the curative effect of bell sore paralysis treated by acupuncture combined with acupoints of distal acupoints. [Methods] Using randomized parallel control method, 100 outpatients were randomly divided into two groups according to random number table method. The control group 50 cases of methimazole 10mg, orally, 3 times / d; vitamin B1 2500μg, vitamin B1 100mg, intramuscular injection, 1 / d. 50 cases of observation group ① far thorn outside the alien, Hegu, Zusanli, foot and other hand and foot acupuncture points, 1 / d, 6 times a week. ② acupoint sticking, each hole 1 paste, 1 time / d, sticking time 8h. Western medicine treatment with the control group. Continuous treatment for 2 weeks for a course of treatment. Observation of clinical symptoms, the number of cases of different treatment cured, adverse reactions. Continuous treatment of 3 courses to determine the efficacy. [Results] The treatment group cured 45 cases, 1 case markedly effective, 3 cases effective, 1 case ineffective, the total effective rate 90.00%; control group cured 27 cases, markedly effective in 10 cases, effective in 11 cases, ineffective in 2 cases, the total effective rate was 54.00% . The treatment group was better than the control group (P <0.05). Two groups of patients with different course of treatment recovery than the treatment group was better than the control group (P <0.05). [Conclusion] Treatment of Bell ’s facial paralysis by means of acupuncture combined with acupoints with distal acupoints and acupoints is effective in shortening the course of treatment and deserving to be popularized and applied.